Wearable technology can help in at-home assessment of myoclonic jerks


Date:
August 5, 2021
Source:
University of Eastern Finland
Summary:
A new study shows that wearable sensor technology can be used to
reliably assess the occurrence of myoclonic jerks in patients with
epilepsy also in the home environment.



FULL STORY ==========================================================================
A new study by the University of Eastern Finland and Kuopio University
Hospital shows that wearable sensor technology can be used to
reliably assess the occurrence of myoclonic jerks in patients with
epilepsy also in the home environment. The method used in the study
was based on the measurement of electrical neuromuscular function and
movement, and it corresponded well to an assessment performed by an
experienced physician. The findings were recently published in Clinical Neurophysiology.


========================================================================== Patients with progressive myoclonic epilepsy (EPM1) suffer from myoclonus, i.e., sudden muscle jerks that are activated by movement and other
stimuli. The severity of these myoclonic jerks varies during the day, and myoclonus can be either positive or negative. A positive myoclonus refers
to a sudden contraction of a muscle, while a negative myoclonus refers
to loss of muscle activation, which in a worst-case scenario may lead
to the fall of a patient, for example. A method for long-term, at-home assessment of myoclonus would facilitate a comprehensive understanding of
its occurrence. Objective measurement data on the occurrence of myoclonic symptoms and on the effect of treatment over hours and days would also
support the development of new drug therapies. Myoclonus also occurs in
other epileptic syndromes and neurological disorders.

The aim of the recently published study was to develop and test a wearable technology-based method for assessing myoclonus symptoms in the home environment. Patients wore a small, wearable sensor on their arm for 48
hours, which measured their muscle function and movement. They also wrote
down their own assessment of the severity of the myoclonus symptom. An algorithm that picks up the occurrence and variation of muscle jerks
from the measurement data was developed to evaluate myoclonus symptoms, describing them as a myoclonus index.

In current clinical practice, the Unified Myoclonus Rating Scale,
UMRS, is used to assess myoclonus symptoms. When using the UMRS, an
experienced physician views a video recording and scores the patient's
symptoms according to their severity. This UMRS assessment provides
information on the occurrence of myoclonus at one point in time. The measurement-based myoclonus index developed in the study correlated
well with the UMRS assessment performed by the physician. Patients'
at-home measurements showed that the measurement-based myoclonus index
was able to detect variation in the occurrence of myoclonus symptoms
during the day and night. The reliability of the measurement results
was also supported by patients' own, at-home assessment and reporting
of their myoclonus symptoms.

According to the study, the myoclonus index can be used to reliably assess positive and negative myoclonus in patients with EPM1. This assessment correlates well with the assessment performed by an experienced physician,
and also makes it possible to assess patients' symptoms in the home environment.

The study was carried out as part of the larger New Modalities
ecosystem funded by Business Finland, involving three universities
and eight companies in Finland. The ecosystem is coordinated by
Orion Corporation. The research group working with patients included researchers from the Department of Applied Physics and the Institute of Clinical Medicine at the University of Eastern Finland, as well as from
the Epilepsy Centre at Kuopio University Hospital. The ecosystem also collaborates with Adamant Health Ltd., which is a spin-off company of
the University of Eastern Finland focusing on software development.

========================================================================== Story Source: Materials provided by University_of_Eastern_Finland. Note: Content may be edited for style and length.


========================================================================== Journal Reference:
1. Saara M. Rissanen, Jelena Hyppo"nen, Katri Silvennoinen, Laura
Sa"isa"nen, Pasi A. Karjalainen, Esa Mervaala, Reetta Ka"lvia"inen.

Wearable monitoring of positive and negative myoclonus in
progressive myoclonic epilepsy type 1. Clinical Neurophysiology,
2021; DOI: 10.1016/ j.clinph.2021.06.026 ==========================================================================

Link to news story: https://www.sciencedaily.com/releases/2021/08/210805141157.htm

--- up 12 weeks, 6 days, 22 hours, 45 minutes
* Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)